Cost-effectiveness of improved primary care treatment of depression in women in Chile

British Journal of Psychiatry

Volumn 197, Issue 4, 2010, Pages 291-296

  Siskind, Dan ^a   Araya, Ricardo ^b   Kim, Jane ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHILE; CLINICAL EVALUATION; COHORT ANALYSIS; COMPUTER MODEL; COST EFFECTIVENESS ANALYSIS; DEPRESSION; FEMALE; HEALTH CARE COST; HUMAN; INCOME; MAJOR CLINICAL STUDY; PATIENT CARE; PRIMARY MEDICAL CARE; QUALITY ADJUSTED LIFE YEAR; RECURRENT DISEASE; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; CHILE; CHRONIC DISEASE; COHORT STUDIES; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GROSS DOMESTIC PRODUCT; HEALTH CARE COSTS; HUMANS; MARKOV CHAINS; MODELS, THEORETICAL; PRIMARY HEALTH CARE; PROGRAM EVALUATION; QUALITY-ADJUSTED LIFE YEARS; RECURRENCE;

EID: 77957678133     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.109.068957     Document Type: Article

References (38)

1. Üstün TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJL. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004; 184: 386-92.
2. Araya R, Rojas G, Fritsch R, Frank R, Lewis G. Inequities in mental health care after health care system reform in Chile. Am J Public Health 2006; 96: 109-13. (Pubitemid 43042840)
3. Saxena S, Thornicroft G, Knapp M, Whiteford H. Resources for mental health: scarcity, inequity, and inefficiency. Lancet 2007; 370: 878-89. (Pubitemid 47362318)
4. Mulrow CD, Williams Jr JW, Chiquette E, Aguilar C, Hitchcock-Noel P, Lee S, et al. Efficacy of newer medications for treating depression in primary care patients. Am J Med 2000; 108: 54-64. (Pubitemid 30058278)
5. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163: 1905-17.
6. Patel V, Araya R, Chatterjee S, Chisholm D, Cohen A, De Silva M, et al. Treatment and prevention of mental disorders in low-income and middle-income countries. Lancet 2007; 370: 991-1005. (Pubitemid 47384829)
7. Araya R, Flynn T, Rojas G, Fritsch R, Simon G. Cost-effectiveness of a primary care treatment program for depression in low-income women in Santiago, Chile. Am J Psychiatry 2006; 163: 1379-87. (Pubitemid 44464408)
8. Araya R, Rojas G, Fritsch R, Gaete J, Rojas M, Simon G, et al. Treating depression in primary care in low-income women in Santiago, Chile: a randomised controlled trial. Lancet 2003; 361: 995-1000.
9. Chisholm D, Sanderson K, Ayuso-Mateos JL, Saxena S. Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions. Br J Psychiatry 2004; 184: 393-403. (Pubitemid 38624765)
10. Siskind D, Baingana F, Kim J. Cost-effectiveness of group psychotherapy for depression in Uganda. J Ment Health Policy Econ 2008; 11: 127-33.
11. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making 1993; 13: 322-38.
12. Eaton WW, Kramer M, Anthony JC, Dryman A, Shapiro S, Locke BZ. The incidence of specific DIS/DSM-III mental disorders: data from the NIMH Epidemiologic Catchment Area Program. Acta Psychiatr Scand 1989; 79: 163-78. (Pubitemid 19070199)
13. Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, Shea MT, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry 2000; 157: 229-33.
14. Stouthard M, Essink-Bot M, Bonsel G. Disability weights for diseases: a modified protocol and results for a Western European region. Eur J Public Health 2000; 10: 24-30. (Pubitemid 30182899)
15. Mahapatra P, Salomon JA, Nanda, L. Measuring health state values in developing countries: results from a community survey in Andhra Pradesh. In Summary of Measures of Population Health: Concepts, Ethics, Measurement and Applications (ed CJL Murray). WHO, 2002.
16. Mathers CD, Murray CJL, Lopez AD, Salomon JA, Saduna R, Tandon A, et al. Estimates of Healthy Life Expectancy for 191 Countries in the Year 2000: Methods and Results. WHO, 2000.
17. Goldney RD, Dal Grande E, Fisher LJ, Wilson D. Population attributable risk of major depression for suicidal ideation in a random and representative community sample. J Affect Disord 2003; 74: 267-72. (Pubitemid 36555926)
18. Heerlein A, Valeria C, Medina B. Seasonal variation in suicidal deaths in Chile: its relationship to latitude. Psychopathology 2006; 39: 75-9. (Pubitemid 43201314)
19. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997; 170: 205-28. (Pubitemid 27117683)
20. Isacsson G, Bergman U, Rich CL. Epidemiological data suggest antidepressants reduce suicide risk among depressives. J Affect Disord 1996; 41: 1-8. (Pubitemid 26364970)
21. Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003; 361: 653-61. (Pubitemid 36246547)
22. Gold MR. Cost-effectiveness in Health and Medicine. Oxford University Press, 1996.
23. World Health Organization. WHO CHOICE (Choosing Interventions that are Cost-Effective). WHO, 2007 (http://www.who.int/choice/en/).
24. The World Bank. World Development Indicators. World Bank, 2008 (http:// publications.worldbank.org/WDI/).
25. World Health Organization. WHO Commission on Macroeconomics and Health. WHO, 2007 (http://www.who.int/macrohealth/en/).
26. HM Treasury. User's Guide: Background Information on GDP and GDP deflator. HM Treasury, 2009 (http://www.hm-treasury.gov.uk/data-gdp-backgd.htm).
27. Central Intelligence Agency. CIA World Factbook. CIA, 2007 (https://www.cia.gov/library/publications/the-world-factbook/geos/ci.html).
28. US Census Bureau. US Census Bureau International Data Base. US Census Bureau, 2009 (http://www.census.gov/ipc/www/idb/country.php).
29. Gaziano TA, Opie LH, Weinstein MC. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 2006; 19; 368: 679-86.
30. Narayan KMV. Diabetes: the pandemic and potential solutions. In Disease Control Priorities in Developing Countries (2nd edn) (eds DT Jamison, JG Breman, AR Measham, G Alleyne, M Claeson, DB Evans, et al): 591-604. World Bank, 2006.
31. Katon W, Rutter C, Ludman EJ, Von Korff M, Lin E, Simon G, et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry 2001; 58: 241-7. (Pubitemid 32209678)
32. Ellis P. Australian and New Zealand clinical practice guidelines for the treatment of depression. Aust N Z J Psychiatry. 2004; 38: 389-407. (Pubitemid 39029045)
33. Vos T, Haby MM, Barendregt JJ, Kruijshaar M, Corry J, Andrews G. The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatry 2004; 61: 1097-103. (Pubitemid 39463410)
34. Jovanovic D, Kilibarda V, Dordevic S, Jovanovic M, Jovic-Stosic J, Srdic D, et al. Bioequivalence testing of a new tablet formulation of generic fluoxetine. Eur J Drug Metab Pharmacokinet 2006; 31: 35-40. (Pubitemid 43736054)
35. Joynt KE, Whellan DJ, O'Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry 2003; 54: 248-61.
36. da Silva Lima AF, de Almeida Fleck MP. Subsyndromal depression: an impact on quality of life? J Affect Disord 2007; 100: 163-9.
37. Broadhead WE, Blazer DG, George LK, Tse CK. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA 1990; 264: 2524-8.
38. Kleinman A. Culture and depression. N Engl J Med 2004; 351: 951-3.